Transgenomic Inc.
12325 Emmet Street
Omaha,
NE 68164
United States - Map
Phone: 402-452-5400
Fax: 402-452-5401
Web Site: http://www.transgenomic.com
| Transgenomic, Inc. provides products for the purification and analysis of nucleic acids used in the life sciences industry for research primarily on molecular genetics and diagnostics. The company also provides genetic variation analytical services to the medical research, clinical, and pharmaceutical markets. Its principal product includes WAVE System, a bioinstrument, which has broad applicability to genetic variation detection in molecular genetic research and molecular diagnostics. The company also offers bioconsumable products, which include SURVEYOR Nuclease and a range of high pressure liquid chromatography separation columns; and consumable products that can be used on multiple independent platforms. In addition, it provides molecular clinical reference laboratory services, which specializes in mitochondrial and molecular diagnostic testing, including genetic testing for oncology, hematology, and inherited disorders, as well as pharmacogenomics research services. The companys customers include academic and medical institutions, as well as pharmaceutical, biotech, and commercial companies. It sells its products through direct sales and support staff in the United States, the United Kingdom, and western Europe; and through dealers and distributors. The company was founded in 1997 and is based in Omaha, Nebraska. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Craig J. Tuttle , 56
Chief Exec. Officer, Pres |
$
303.00K | N/A | Ms. Debra A. Schneider , 50
Chief Financial Officer, Principal Accounting Officer, VP, Sec. and Treasurer |
$
207.00K | N/A | Dr. Eric Kaldjian M.D., 47
Chief Scientific Officer |
$
220.00K | N/A | Mr. William P. Rasmussen , 56
Head of HR & Admin. and Head of Strategic Planning |
N/A
| N/A | Dr. Leonid Beigelman Ph.D.,
Head of Chemistry R&D |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.29% Nasdaq 
Profile
